No Racial Differences Found in Access to Biologics: A Population-Based Study of Psoriasis Patients in the United States

August 2023 | Volume 22 | Issue 8 | Editorials | 835 | Copyright © August 2023

Background: Conflicting evidence exists regarding the role of race in access to biologics for patients with psoriasis. Objective: To compare biologic use among adult and pediatric Uni...
Read More

Diagnosis and Management of Pediatric Psoriasis: An Overview for Pediatricians

August 2023 | Volume 22 | Issue 8 | Original Article | 742 | Copyright © August 2023

The Overview of the Immunobiology of Interleukin-23 Associated With Immune-Mediated Inflammatory Disorders: A Narrative Review

April 2023 | Volume 22 | Issue 4 | Original Article | 375 | Copyright © April 2023

Evolving Concepts in Psoriasis: Special Considerations for Patients With Skin of Color, Skin Barrier Dysfunction, and the Role of Adjunctive Skin Care

October 2022 | Volume 21 | Issue 10 | Original Article | 1054 | Copyright © October 2022

Background: Despite considerable advances in our understanding of the pathogenesis and treatment of psoriasis, data pertaining to racial/ethnic variations, effects on barrier function...
Read More

Severe Psoriasis Presenting in 3-Year-Old Child With Nail Dystrophy: Response to Biologic Treatment

August 2022 | Volume 21 | Issue 8 | Case Reports | 897 | Copyright © August 2022

Psoriasis, a chronic inflammatory skin condition, affects about 2% of children. A small subset have isolated nail involvement refractory to topical treatment that can be disabling. The development of ...
Read More

Tumor Necrosis Factor Inhibitor-Induced Psoriasis in a Pediatric Crohn’s Disease Patient Successfully Treated with Ustekinumab

March 2020 | Volume 19 | Issue 3 | Case Reports | 328 | Copyright © March 2020

Background: Tumor necrosis factor (TNF) inhibitors are widely used in pediatric patients with inflammatory bowel disease, as well as psoriasis. However, there is growing evidence that...
Read More

Prevalence of Psoriasis in Children and Adolescents in the United States: A Claims-Based Analysis

February 2018 | Volume 17 | Issue 2 | Original Article | 187 | Copyright © February 2018

IMPORTANCE: While psoriasis (Ps) is mainly characterized as an adult disease, it can also ...
Read More

Adalimumab in Chronic Plaque Psoriasis: A Clinical Guide

August 2017 | Volume 16 | Issue 8 | Original Article | 779 | Copyright © August 2017

Psoriasis is a common, inflammatory disease that manifests itself as lesions on the skin, which greatly impacts the physical and psychological wellbeing of those affected. The current goal of treat...
Read More

Clinical Trial Report

April 2015 | Volume 14 | Issue 4 | Features | 424 | Copyright © April 2015

Clinical Trial Review is a JDD department designed to provide physicians with information on drugs and devices undergoing clinical testing. It is our goal to inform the reader of the status of select ...
Read More

Combination Therapy for Psoriasis in the United States

May 2013 | Volume 12 | Issue 5 | Original Article | 546 | Copyright © May 2013

BACKGROUND: Psoriasis is treated with several classes of treatments that may be used in combination, but the ways combination therapies are used are not well characterized.
PURPOSE: To determine...
Read More

Assessor-Blinded Study of the Metabolic Syndrome and Surrogate Markers of Increased Cardiovascular Risk in Children With Moderate-to-Severe Psoriasis Compared With Age-Matched Population of Children With Warts

August 2011 | Volume 10 | Issue 8 | Original Article | 900 | Copyright © August 2011

Adult patients with psoriasis have an increased prevalence of the metabolic syndrome (MetS) and cardiovascular disease (CVD) risk factors due to ele...
Read More

Use of Biologic Agents in Pediatric Psoriasis

August 2010 | Volume 9 | Issue 8 | Original Article | 975 | Copyright © August 2010

Psoriasis affects approximately 2 percent of the population. Approximately 30–45 percent of those affected first experience symptoms during childhood or adolescence. Although biologics have proven ...
Read More